EquityFlowCompanies › Tolemy Bio

Tolemy Bio

Biotech · GB

Data platform helping cell and gene therapy developers exploit their experimental data, a 'Google Maps for cells'.

Funding history

DateRoundAmount
May 2026Pre Seed
Tolemy Bio (UK) closed a 1.4M euro pre-seed led by Norrsken Evolve to help cell and gene therapy developers exploit their experimental data.
$1.6M

Investors

Norrsken Evolve

Similar companies in Biotech

Explore funding flow on EquityFlow →